** = Publikationen gelistet in SCI/SSCI/Pubmed
** Azhar, K; Ramirez-Obermayer, A; Sourij, C; Knoll, L; Andritz, E; Kojzar, H; Müller, A; Moser, O; Tripolt, NJ; Pferschy, PN; Aziz, F; Sourij, H
Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin-treated type 2 diabetes-Two-year follow-up of the randomised controlled InterFast-2 trial.
Diabetes Obes Metab. 2025; 27(3):1605-1608
Doi: 10.1111/dom.16158
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kreuzer, K; Birkl-Toeglhofer, AM; Haybaeck, J; Reiter, A; Dalkner, N; Fellendorf, FT; Maget, A; Platzer, M; Seidl, M; Mendel, LM; Lenger, M; Birner, A; Queissner, R; Mairinger, M; Obermayer, A; Kohlhammer-Dohr, A; Stross, TM; Häussl, A; Hamm, C; Schöggl, H; Amberger-Otti, D; Painold, A; Lahousen-Luxenberger, T; Leitner-Afschar, B; Färber, T; Mörkl, S; Wagner-Skacel, J; Meier-Allard, N; Lackner, S; Holasek, S; Habisch, H; Madl, T; Reininghaus, E; Bengesser, SA
PROVIT-CLOCK: A Potential Influence of Probiotics and Vitamin B7 Add-On Treatment and Metabolites on Clock Gene Expression in Major Depression.
Neuropsychobiology. 2024; 83(3-4):135-151
Doi: 10.1159/000538781
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pammer, A; Obermayer, A; Stadler, JT; Pferschy, PN; Tripolt, NJ; Habisch, H; Madl, T; Sourij, H; Marsche, G
Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial.
Cardiovasc Diabetol. 2024; 23(1): 339
Doi: 10.1186/s12933-024-02426-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Lenz, J; Mursic, I; Sternad, C; Hönger, L; Ziko, H; Pferschy, PN; Tripolt, N; Sourij, H
Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study).
Diabetes Technol Ther. 2023; 25(3):161-168
Doi: 10.1089/dia.2022.0422
Web of Science
PubMed
FullText
FullText_MUG
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Müller, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Habisch, H; Madl, T; Pieber, T; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Diabetes Care. 2023; 46(2):463-468
Doi: 10.2337/dc22-1622
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Paar, M; Aziz, F; Sourij, C; Tripolt, NJ; Kojzar, H; Müller, A; Pferschy, P; Obermayer, A; Banfic, T; Di, Geronimo, Quintero, B; Goswami, N; Schlagenhauf, A; Köstenberger, M; Bärnthaler, T; Wagner, T; Hrzenjak, A; Wonisch, W; Reibnegger, G; Raggam, RB; Sourij, H; Cvirn, G
Only Subclinical Alterations in the Haemostatic System of People with Diabetes after COVID-19 Vaccination.
Viruses. 2023; 15(1): 10
Doi: 10.3390/v15010010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reintar, S; Pochhacker, M; Obermayer, A; Eberhard, K; Zirlik, A; Verheyen, N; von Lewinski, D; Scherr, D; Hutz, B; Haudum, CW; Pieber, TR; Sourij, H; Obermayer-Pietsch, B
Urinary C-Peptide to Creatinine Ratio (UCPCR) as Indicator for Metabolic Risk in Apparently Healthy Adults-A BioPersMed Cohort Study
NUTRIENTS. 2023; 15(9): 2073
Doi: 10.3390/nu15092073
Web of Science
FullText
FullText_MUG
** Reintar, S; Pöchhacker, M; Obermayer, A; Eberhard, K; Zirlik, A; Verheyen, N; von, Lewinski, D; Scherr, D; Hutz, B; Haudum, CW; Pieber, TR; Sourij, H; Obermayer-Pietsch, B
Urinary C-Peptide to Creatinine Ratio (UCPCR) as Indicator for Metabolic Risk in Apparently Healthy Adults-A BioPersMed Cohort Study.
Nutrients. 2023; 15(9):
Doi: 10.3390/nu15092073
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Schweighofer, N; Strasser, M; Obermayer, A; Trummer, O; Sourij, H; Sourij, C; Obermayer-Pietsch, B
Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects.
Genes (Basel). 2023; 14(8): 1609
Doi: 10.3390/genes14081609
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Aziz, F; Kojzar, H; Obermayer, AM; Sternad, C; Müller, A; Tripolt, NJ; Pferschy, PN; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Steinmetz, I; Sourij, H
Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2023; 25(1): 314-318.
Doi: 10.1111/dom.14855
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Birnbaumer, P; Pferschy, P; Tripolt, N; Sourij, H
Measurement Accuracy of simultaneously used rt-CGM compared to isCGM during Exercise in Adults with Type 1 Diabetes: An exploratory Analysis of the ULTRAFLEXI-1 Study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S770-S770.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Moser, O; Müller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Birnbaumer, P; Pferschy, PN; Tripolt, N; Sourij, H
Performance of simultaneously used real-time CGM versus intermittently scanned CGM around exercise in type 1 diabetes: an exploratory analysis of the ULTRAFLEXI-1 study
DIABETOLOGIA. 2023; 66(SUPPL 1):S404-S404.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY.
[Oral Communication]
Web of Science
** Tripolt, N; Knoll, L; Pferschy, P; Andritz, E; Obermayer, A; Moser, O; Aziz, F; Sourij, C; Sourij, H
Intermittent Fasting in Patients with Type 2 Diabetes mellitus-2-Year Follow-up Data of the InterFast 2 Study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S764-S765.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Jacan, A; Schauer, M; Aziz, F; Oulhaj, A; Aberer, F; Sourij, C; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
INTERmittent FASTing in people with insulin-treated type 2 diabetes mellitus - the INTERFAST-2 study protocol.
Diabet Med. 2022; 39(6):e14813
Doi: 10.1111/dme.14813
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Sourij, C; Tripolt, NJ; Aziz, F; Aberer, F; Forstner, P; Obermayer, AM; Kojzar, H; Kleinhappl, B; Pferschy, PN; Mader, JK; Cvirn, G; Goswami, N; Wachsmuth, N; Eckstein, ML; Müller, A; Abbas, F; Lenz, J; Steinberger, M; Knoll, L; Krause, R; Stradner, M; Schlenke, P; Sareban, N; Prietl, B; Kaser, S; Moser, O; Steinmetz, I; Sourij, H, , COVAC-DM, study, group
Humoral immune response to COVID-19 vaccination in diabetes is age-dependent but independent of type of diabetes and glycaemic control: The prospective COVAC-DM cohort study.
Diabetes Obes Metab. 2022; 24(5):849-858
Doi: 10.1111/dom.14643
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Moser, O; Aziz, F; Sourij, C; Ziko, H; Lenz, J; Abbas, F; Obermayer, AM; Kojzar, H; Pferschy, PN; Müller, A; Unteregger, C; Leitner, M; Banfic, T; Eckstein, ML; Wachsmuth, N; Kaser, S; Mader, JK; Tripolt, NJ; Sourij, H
Impact of COVID-19 Vaccination on Glycemia in Individuals With Type 1 and Type 2 Diabetes: Substudy of the COVAC-DM Study.
Diabetes Care. 2022; 45(2): e24-e26.
Doi: 10.2337/dc21-1563
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Muller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Birnbaumer, P; Eckstein, M; Honger, L; Lenz, J; Mursic, I; Sternad, C; Weber, B; Zanker, M; Ziko, H; Pferschy, P; Tripolt, N; Sourij, H
A comparison of Insulin Glargine U300 and Insulin Degludec around spontaneous exercise sessions in people with type 1 diabetes - the ULTRAFLEXI-1 study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):251-251.
[Oral Communication]
Web of Science
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Intermittent fasting is safe and improves metabolic parameters in people with insulin treated type 2 diabetes: a randomised controlled trial
DIABETOLOGIA. Abstracts 58th Annual Meeting of the EASD. 2022; 65(SUPPL 1):S276-S276.-58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 19-23, 2022; Stockholm, SWEDEN.
[Oral Communication]
Web of Science
** Obermayer, A; Tripolt, NJ; Pferschy, PN; Kojzar, H; Aziz, F; Muller, A; Jacan, A; Schauer, M; Oulhaj, A; Aberer, F; Sourij, C; Pieber, TR; Obermayer-Pietsch, B; Stadlbauer, V; Sourij, H
Intermittent fasting is safe and improves metabolic parameters in people with insulin-treated type 2 diabetes mellitus a randomized controlled trial
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):252-253.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Sourij, C; Aziz, F; Kojzar, H; Obermayer, A; Sternad, C; Forstner, P; Muller, A; Tripolt, N; Pferschy, P; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Sourij, H
SARS-CoV-2S antibody formation is not impaired in people with type 1 or type 2 diabetes, but the antibody level falls more rapidly in this collective - the -COVAC-DM study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):259-260.
[Oral Communication]
Web of Science
** Sourij, H; Mueller, A; Aberer, F; Aziz, F; Kojzar, H; Sourij, C; Obermayer, A; Abbas, F; Eckstein, ML; Lenz, J; Sternad, C; Pferschy, PN; Tripolt, NJ; Ziko, H; Moser, O
Insulin glargine u300 versus insulin degludec around spontaneous exercise sessions in people with type 1 diabetes: the Ultraflexi-1 study
DIABETOLOGIA. 2022; 65(SUPPL 1):S220-S221.
[Oral Communication]
Web of Science
** Eckstein, ML; Moser, O; Tripolt, NJ; Pferschy, PN; Obermayer, AAM; Kojzar, H; Mueller, A; Abbas, F; Sourij, C; Sourij, H
Rapid glucose rise reduces heart rate variability in adults with type 1 diabetes: A prospective secondary outcome analysis.
Diabetes Obes Metab. 2021; 23(7):1681-1684
Doi: 10.1111/dom.14287
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Eckstein, ML; Mueller, A; Tripolt, NJ; Yildirim, H; Abbas, F; Pferschy, PN; Goswami, N; Aberer, F; Obermayer, A; Pieber, TR; Kojzar, H; Sourij, C; Brunner, M; Niedrist, T; Herrmann, M; Sourij, H
Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes - A Cross-Over Controlled Trial.
FRONT ENDOCRINOL. 2021; 12: 656346
Doi: 10.3389/fendo.2021.656346
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Tripolt, N; Pferschy, P; Obermayer, A; Kojzar, H; Mueller, A; Yildirim, H; Sourij, C; Eckstein, M; Sourij, H
Performance of the Intermittently Scanned Continuous Glucose Monitoring (isCGM) System during a High Oral Glucose Challenge in Adults with Type 1 Diabetes-A Prospective Secondary Outcome Analysis.
BIOSENSORS-BASEL. 2021; 11(1):
Doi: 10.3390/bios11010022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Obermayer, A; Tripolt, NJ; Aziz, F; Högenauer, C; Aberer, F; Schreiber, F; Eherer, A; Sourij, C; Stadlbauer, V; Svehlikova, E; Brunner, M; Goswami, N; Kojzar, H; Pferschy, PN; Pieber, TR; Sourij, H
EndoBarrier™ Implantation Rapidly Improves Insulin Sensitivity in Obese Individuals with Type 2 Diabetes Mellitus.
Biomolecules. 2021; 11(4):
Doi: 10.3390/biom11040574
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Moser, O; Sourij, C; Aziz, F; Ziko, H; Muller, A; Obermayer, AM; Kojzar, H; Pferschy, PN; Leitner, M; Lenz, J; Abbas, F; Banfic, T; Eckstein, ML; Wachsmuth, N; Tripolt, N; Kaser, S; Mader, JK; Sourij, H
The immediate Impact of the COVID-19 Vaccination on the Time in Range and the Bolus Insulin Dose in People with Type 1 Diabetes - Subgroup Analysis of a multicenter Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):222-222.
[Oral Communication]
Web of Science
** Obermayer, A; Sourij, C; Aziz, F; von Lewinski, F; Kojzar, H; Pferschy, PN; Abbas, F; von Lewinski, D; Lenz, J; Tripolt, NJ; Aberer, F; Sourij, H
Assessment of Insulin Secretion using the C-Peptide/Glucose Ratio (CGR) in People with Type 2 Diabetes mellitus and Insulin Therapy - Data from the Graz Diabetes Register for Biomarker Research (GIRO)
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):227-227.
[Oral Communication]
Web of Science
** Tripolt, N; Sourij, C; Aberer, F; Kojzar, H; Obermayer, A; Pferschy, P; Aziz, F; Muller, A; Abbas, F; Lenz, J; Mader, J; Pesto, L; Banfic, T; Leitner, M; Steinberger, M; Knoll, L; Goswami, N; Moser, O; Eckstein, M; Wachsmuth, N; Cvirn, G; Stradner, M; Schlenke, P; Kaser, S; Steinmetz, I; Sourij, H
Immune Response to COVID-19 Vaccination for Patients with Diabetes mellitus - The Covac-DM Austria Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):228-228.
[Oral Communication]
Web of Science
** Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C; Obermayer, AM; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
Diabetes Obes Metab. 2020; 22(2):212-221
Doi: 10.1111/dom.13889
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moser, O; Mueller, A; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H
Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
PLoS One. 2020; 15(9): e0239091-e0239091.
Doi: 10.1371/journal.pone.0239091
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lennart, M; Moser, EO; Ziko, H; Tripolt, N; Pferschy, PN; Obermayer, AMA; Kojzar, H; Muller, A; Linhart, C; Sourij, C; Sourij, H
The Impact of Glycemia and the Glucose Change Rate on Heart Rate Variability in People with Type 1 Diabetes - A prospective secondary Analysis.
WIEN KLIN WOCHENSCHR. 2020; 132: S346-S346.virtuell.
[Poster]
Web of Science
** Muller, A; Moser, O; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H
Halving the Basal Insulin Dose before a Running Event in physically active Adults with Type 1 Diabetes minimizes the Risk of Hypoglycaemia - A prospective, clinical, controlled, Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S364-S364.
[Onlinepräsentation]
Web of Science
** Muller, A; Moser, O; Tripolt, N; Pferschy, P; Obermayer, A; Kojzar, H; Yildirim, H; Sourij, C; Eckstein, ML; Sourij, H
Measurement Accuracy of the intermittently-scanned continuous Glucose Monitoring Devices (isCGM) during a glycemic Challenge in Adults with Type 1 Diabetes - A prospective Analysis.
WIEN KLIN WOCHENSCHR. 2020; 132: S364-S364.
[Poster]
Web of Science
** Obermayer, A; Sourij, C; Aziz, F; Kojzar, H; Pferschy, PN; Abbas, F; Lenz, J; Tripolt, N; Aberer, F; Sourij, H
Stages of CKD and cardiovascular Risk in Persons with Diabetes mellitus: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S362-S363.
[Poster]
Web of Science
** Sourij, C; Stauber, R; Aziz, F; Kojzar, H; Obermayer, A; Pferschy, P; Tripolt, N; Aberer, F; Sourij, H
NAFLD in Patients with Diabetes mellitus and Lipid Metabolism Disorders: Data from the Graz Diabetes Registry for Biomarker Research GIRO.
WIEN KLIN WOCHENSCHR. 2020; 132: S344-S345.
[Poster]
Web of Science
** Tripolt, NJ; Pferschy, PN; Obermayer, A; Kojzar, H; Obermayer, B; Zanker, M; Sourij, C; Pieber, TR; Moser, O; Eckstein, ML; Riedl, R; Sourij, H
Adaptive insuline and glucose metabolism upon prolonged fasting in non-obese but not in obese individuals.
DIABETOLOGIA. 2020; 63(SUPPL 1):S296-S297.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK.
[Poster]
Web of Science
** Tripolt, NJ; Pferschy, PN; Obermayer, A; Kojzar, H; Obermayer-Pietsch, B; Zanker, M; Muller, A; Sourij, C; Moser, O; Eckstein, M; Pieber, T; Riedl, R; Sourij, H
Glucose Metabolism after 12 Hours and 36 Hours of Fasting in People with different Glucose Tolerance.
WIEN KLIN WOCHENSCHR. 2020; 132: S361-S361.
[Poster]
Web of Science
** Tripolt, NJ; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Sourij, C; Obermayer, AM; Stadlbauer, V; Svehlikova, E; Brunner, M; Kojzar, H; Pferschy, PN; Pieber, TR; Sourij, H
Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial.
Diabetes Ther. 2019; 10(1):299-309
Doi: 10.1007/s13300-018-0540-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Pferschy, P; Tripolt, N; Sourij, C; Obermayer, AM; Pruller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to Platelet- and Coagulation Activation in Patients with Type 2 Diabetes under Metformin-Monotherapy - Results of hyperinsulinaemic hypoglycaemic Clamp-Study
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S461-S462.
[Poster]
Web of Science
** Aberer, F; Tripolt, N; Pferschy, P; Pruller, F; Riedl, R; Aziz, F; Obermayer, A; Kojzar, H; Stojakovic, T; Scharnagl, H; Oulhaj, A; Sourij, C; Brunner, M; Novak, E; Sourij, H
Acute and prolonged effects of clamp-induced hypoglycaemia on procoagulatory markers in subjects with type 2 diabetes treated with metformin only
DIABETOLOGIA. 2019; 62: S417-S417.
[Poster]
Web of Science
** Sourij, C; Obermayer, A; Kojzar, H; Kofler, L; Dzankovic, F; Anoptchenko, V; Pferschy, P; Obermayer-Pietsch, B; Stach, E; Oulhaj, A; Aziz, F; Sourij, H
Persistent Proinsulin Secretion in Patients with DM1-what is really measured?
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471.
[Oral Communication]
Web of Science
** Sourij, C; Obermayer, A; Sourij, H
SGLT-inhibitors as a therapeutic option for patients with type 1 diabetes
AUST J CLIN ENDOCR M. 2018; 11(4): 122-126.
Doi: 10.1007/s41969-018-0050-7
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Pferschy, P; Tripolt, N; Url, J; Aberer, F; Hogenauer, C; Schreiber, F; Eherer, A; Sourij, C; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal liner in obese subjects with type 2 diabetes - Sustainable effects on insulin sensitivity after explantation
WIEN KLIN WOCHENSCHR. 2018; 130: 374-374.
[Oral Communication]
Web of Science
** Pferschy, PN; Tripolt, NJ; Aberer, F; Url, J; Högenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, C; Sourij, H
Endobarrier in obese People with Type-2 Diabetes: Short- and Medium-term Effects on the Glucose Metabolism
WIEN KLIN WOCHENSCHR. 2017; 129(19-20):732-732.
[Poster]
Web of Science
** Tripolt, N; Aberer, F; Pferschy, P; Sourij, C; Url, J; Hogenauer, C; Schreiber, F; Eherer, A; Svehlikova, E; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: 161-161.
[Poster]
Web of Science
FullText
** Tripolt, N; Aberer, F; Url, J; Pferschy, P; Hogenauer, C; Schreiber, F; Eherer, A; Sourij, C; Obermayer, AM; Stadlbauer, V; Sourij, H
Endobarrier (R) gastrointestinal bypass-liner in obese subjects with type 2 diabetes: short- and mid-term effects on glucose metabolism
WIEN KLIN WOCHENSCHR. 2017; 129: S123-S123.
Web of Science
** Tripolt, N; Aberer, F; Schreiber, F; Url, J; Eherer, A; Sourij, C; Obermayer, A; Stadlbauer, V; Hogenauer, C; Sourij, H
Pilot Study for the Monitoring of Short-Term Metabolic Effects after Implantation of a Duodeno-Jejunal Bypass Liner (EndoBarrier (R)) in adipose Patients with Diabetes Mellitus Type 2
WIEN KLIN WOCHENSCHR. 2016; 128: S421-S422.
[Oral Communication]
Web of Science